Author:
Shi Zhen-yu,Li Yong-qiang,Kang Yu-hua,Hu Guo-qiang,Huang-Fu Chao-shen,Deng Jin-bo,Liu Bin
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference34 articles.
1. Bolon MK . The newer fluoroquinolones. Infect Dis Clin North Am 2009; 23: 1027–51.
2. Bax BD, Chan PF, Eggleston DS, Fosberry A, Gentry DR, Gorrec F, et al. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature 2010; 466: 935–40.
3. Rajabalian S, Foroumadi A, Shafiee A, Emami S . Functionalized N-(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents. J Pharm Pharm Sci 2007; 10: 153–8.
4. Yamashita Y, Ashizawa T, Morimoto M, Hosomi J, Nakano H . Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity. Cancer Res 1992; 52: 2818–22.
5. Kamat AM, DeHaven JI, Lamm DL . Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Urology 1999; 54: 56–61.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献